Index by author

December 01 1999; volume 22 issue 12

A

  1. Adèr, H J

    1. The 12-item well-being questionnaire. An evaluation of its validity and reliability in Dutch people with diabetes.
      F Pouwer, H M van der Ploeg, H J Adèr, R J Heine and F J Snoek
      Diabetes Care 1999 Dec; 22 (12): 2004-2010. https://doi.org/10.2337/diacare.22.12.2004

  2. Aharon, Y

    1. Transcutaneous glucose measurement using near-infrared spectroscopy during hypoglycemia.
      I Gabriely, R Wozniak, M Mevorach, J Kaplan, Y Aharon and H Shamoon
      Diabetes Care 1999 Dec; 22 (12): 2026-2032. https://doi.org/10.2337/diacare.22.12.2026

  3. Akerblom, H K

    1. Clinical, autoimmune, and genetic characteristics of very young children with type 1 diabetes. Childhood Diabetes in Finland (DiMe) Study Group.
      J Komulainen, P Kulmala, K Savola, R Lounamaa, J Ilonen, H Reijonen, M Knip and H K Akerblom
      Diabetes Care 1999 Dec; 22 (12): 1950-1955. https://doi.org/10.2337/diacare.22.12.1950
    2. Infant feeding, early weight gain, and risk of type 1 diabetes. Childhood Diabetes in Finland (DiMe) Study Group.
      E Hyppönen, M G Kenward, S M Virtanen, A Piitulainen, P Virta-Autio, J Tuomilehto, M Knip and H K Akerblom
      Diabetes Care 1999 Dec; 22 (12): 1961-1965. https://doi.org/10.2337/diacare.22.12.1961

  4. Albertini, J P

    1. Soluble L-selectin level is a marker for coronary artery disease in type 2 diabetic patients.
      J P Albertini, P Valensi, B Lormeau, J Vaysse, J R Attali and L Gattegno
      Diabetes Care 1999 Dec; 22 (12): 2044-2048. https://doi.org/10.2337/diacare.22.12.2044

  5. Altman, J J

    1. Safety of human insulin in poor-sighted elderly diabetic patients.
      J J Altman, N Elian, M Bonnemaire, S Calmar and S Feldman
      Diabetes Care 1999 Dec; 22 (12): 2089. https://doi.org/10.2337/diacare.22.12.2089b

  6. Anderson, C M

    1. Youth-onset type 2 diabetes (Y2DM) associated with HNF1A S319 in aboriginal Canadians.
      R A Hegele, A J Hanley, B Zinman, S B Harris and C M Anderson
      Diabetes Care 1999 Dec; 22 (12): 2095-2096. https://doi.org/10.2337/diacare.22.12.2095

  7. Anderson, R M

    1. In diabetes care, moving from compliance to adherence is not enough. Something entirely different is needed.
      R E Glasgow and R M Anderson
      Diabetes Care 1999 Dec; 22 (12): 2090-2092. https://doi.org/10.2337/diacare.22.12.2090

  8. Asplund, K

    1. Screening for impaired glucose tolerance. Results from a population-based study in 21,057 individuals.
      B Lindahl, L Weinehall, K Asplund and G Hallmans
      Diabetes Care 1999 Dec; 22 (12): 1988-1992. https://doi.org/10.2337/diacare.22.12.1988

  9. Atkinson, A B

    1. Relationship of endothelial function to birth weight in humans.
      A S McAllister, A B Atkinson, G D Johnston and D R McCance
      Diabetes Care 1999 Dec; 22 (12): 2061-2066. https://doi.org/10.2337/diacare.22.12.2061

  10. Attali, J R

    1. Soluble L-selectin level is a marker for coronary artery disease in type 2 diabetic patients.
      J P Albertini, P Valensi, B Lormeau, J Vaysse, J R Attali and L Gattegno
      Diabetes Care 1999 Dec; 22 (12): 2044-2048. https://doi.org/10.2337/diacare.22.12.2044

B

  1. Bald, E

    1. Total plasma homocysteine and insulin levels in type 2 diabetic patients with secondary failure to oral agents.
      J Drzewoski, L Czupryniak, G Chwatko and E Bald
      Diabetes Care 1999 Dec; 22 (12): 2097-2099. https://doi.org/10.2337/diacare.22.12.2097

  2. Belicar, P

    1. Assessment of in vivo stability of a new insulin preparation for implantable insulin pumps. A randomized multicenter prospective trial. EVADIAC Group. Evaluation Dans le diabète du Traitement par Implants Actifs.
      S Boivin, P Belicar and V Melki
      Diabetes Care 1999 Dec; 22 (12): 2089-2090. https://doi.org/10.2337/diacare.22.12.2089a

  3. Berntorp, E

    1. Progression of retinopathy after improved metabolic control in type 2 diabetic patients. Relation to IGF-1 and hemostatic variables.
      M Henricsson, K Berntorp, E Berntorp, P Fernlund and G Sundkvist
      Diabetes Care 1999 Dec; 22 (12): 1944-1949. https://doi.org/10.2337/diacare.22.12.1944

  4. Berntorp, K

    1. Progression of retinopathy after improved metabolic control in type 2 diabetic patients. Relation to IGF-1 and hemostatic variables.
      M Henricsson, K Berntorp, E Berntorp, P Fernlund and G Sundkvist
      Diabetes Care 1999 Dec; 22 (12): 1944-1949. https://doi.org/10.2337/diacare.22.12.1944

  5. Bhattacharyya, A

    1. Insulin lispro, pregnancy, and retinopathy.
      A Bhattacharyya and P A Vice
      Diabetes Care 1999 Dec; 22 (12): 2101-2104. https://doi.org/10.2337/diacare.22.12.2101

  6. Bingley, P J

    1. Progression to diabetes in relatives with islet autoantibodies. Is it inevitable?
      S G Gardner, E A Gale, A J Williams, K M Gillespie, K E Lawrence, G F Bottazzo and P J Bingley
      Diabetes Care 1999 Dec; 22 (12): 2049-2054. https://doi.org/10.2337/diacare.22.12.2049

  7. Bloomgarden, Z T

    1. American Diabetes Association Annual Meeting, 1999. New approaches to insulin treatment and glucose monitoring.
      Z T Bloomgarden
      Diabetes Care 1999 Dec; 22 (12): 2078-2082. https://doi.org/10.2337/diacare.22.12.2078

  8. Bo, S

    1. Prevalence of patients reaching the targets of good control in normal clinical practice. A cohort-based study in type 2 diabetes.
      S Bo, P Cavallo-Perin and L Gentile
      Diabetes Care 1999 Dec; 22 (12): 2092. https://doi.org/10.2337/diacare.22.12.2092b

  9. Boemi, M

    1. Renal disease as a determinant of increased lipoprotein(a) concentrations in diabetic patients.
      M Boemi, C Sirolla, P Fumelli and R W James
      Diabetes Care 1999 Dec; 22 (12): 2033-2036. https://doi.org/10.2337/diacare.22.12.2033

  10. Boivin, S

    1. Assessment of in vivo stability of a new insulin preparation for implantable insulin pumps. A randomized multicenter prospective trial. EVADIAC Group. Evaluation Dans le diabète du Traitement par Implants Actifs.
      S Boivin, P Belicar and V Melki
      Diabetes Care 1999 Dec; 22 (12): 2089-2090. https://doi.org/10.2337/diacare.22.12.2089a

  11. Bonnemaire, M

    1. Safety of human insulin in poor-sighted elderly diabetic patients.
      J J Altman, N Elian, M Bonnemaire, S Calmar and S Feldman
      Diabetes Care 1999 Dec; 22 (12): 2089. https://doi.org/10.2337/diacare.22.12.2089b

  12. Bortolotti, N

    1. Meal-generated oxidative stress in diabetes. The protective effect of red wine.
      A Ceriello, N Bortolotti, E Motz, S Lizzio, A Russo, V Selmo, B Catone, L Tonutti and C Taboga
      Diabetes Care 1999 Dec; 22 (12): 2084-2085. https://doi.org/10.2337/diacare.22.12.2084

  13. Bottazzo, G F

    1. Progression to diabetes in relatives with islet autoantibodies. Is it inevitable?
      S G Gardner, E A Gale, A J Williams, K M Gillespie, K E Lawrence, G F Bottazzo and P J Bingley
      Diabetes Care 1999 Dec; 22 (12): 2049-2054. https://doi.org/10.2337/diacare.22.12.2049

  14. Bryden, K S

    1. Eating habits, body weight, and insulin misuse. A longitudinal study of teenagers and young adults with type 1 diabetes.
      K S Bryden, A Neil, R A Mayou, R C Peveler, C G Fairburn and D B Dunger
      Diabetes Care 1999 Dec; 22 (12): 1956-1960. https://doi.org/10.2337/diacare.22.12.1956

  15. Burge, M R

    1. Low-dose ethanol predisposes elderly fasted patients with type 2 diabetes to sulfonylurea-induced low blood glucose.
      M R Burge, T M Zeise, T A Sobhy, A G Rassam and D S Schade
      Diabetes Care 1999 Dec; 22 (12): 2037-2043. https://doi.org/10.2337/diacare.22.12.2037

C

  1. Calmar, S

    1. Safety of human insulin in poor-sighted elderly diabetic patients.
      J J Altman, N Elian, M Bonnemaire, S Calmar and S Feldman
      Diabetes Care 1999 Dec; 22 (12): 2089. https://doi.org/10.2337/diacare.22.12.2089b

  2. Catone, B

    1. Meal-generated oxidative stress in diabetes. The protective effect of red wine.
      A Ceriello, N Bortolotti, E Motz, S Lizzio, A Russo, V Selmo, B Catone, L Tonutti and C Taboga
      Diabetes Care 1999 Dec; 22 (12): 2084-2085. https://doi.org/10.2337/diacare.22.12.2084

  3. Cavallo-Perin, P

    1. Prevalence of patients reaching the targets of good control in normal clinical practice. A cohort-based study in type 2 diabetes.
      S Bo, P Cavallo-Perin and L Gentile
      Diabetes Care 1999 Dec; 22 (12): 2092. https://doi.org/10.2337/diacare.22.12.2092b

  4. Ceriello, A

    1. Meal-generated oxidative stress in diabetes. The protective effect of red wine.
      A Ceriello, N Bortolotti, E Motz, S Lizzio, A Russo, V Selmo, B Catone, L Tonutti and C Taboga
      Diabetes Care 1999 Dec; 22 (12): 2084-2085. https://doi.org/10.2337/diacare.22.12.2084

  5. Chan, J C

    1. Two-hour post-glucose loading plasma glucose is the main determinant for the progression from impaired glucose tolerance to diabetes in Hong Kong Chinese.
      G T Ko, J K Li, A Y Cheung, V T Yeung, C C Chow, L W Tsang, C S Cockram and J C Chan
      Diabetes Care 1999 Dec; 22 (12): 2096-2097. https://doi.org/10.2337/diacare.22.12.2096

  6. Chang, C J

    1. Discriminating glucose tolerance status by regions of interest of dual-energy X-ray absorptiometry. Clinical implications of body fat distribution.
      C J Chang, C H Wu, F H Lu, J S Wu, N T Chiu and W J Yao
      Diabetes Care 1999 Dec; 22 (12): 1938-1943. https://doi.org/10.2337/diacare.22.12.1938

  7. Cheung, A Y

    1. Two-hour post-glucose loading plasma glucose is the main determinant for the progression from impaired glucose tolerance to diabetes in Hong Kong Chinese.
      G T Ko, J K Li, A Y Cheung, V T Yeung, C C Chow, L W Tsang, C S Cockram and J C Chan
      Diabetes Care 1999 Dec; 22 (12): 2096-2097. https://doi.org/10.2337/diacare.22.12.2096

  8. Chiu, N T

    1. Discriminating glucose tolerance status by regions of interest of dual-energy X-ray absorptiometry. Clinical implications of body fat distribution.
      C J Chang, C H Wu, F H Lu, J S Wu, N T Chiu and W J Yao
      Diabetes Care 1999 Dec; 22 (12): 1938-1943. https://doi.org/10.2337/diacare.22.12.1938

  9. Chow, C C

    1. Two-hour post-glucose loading plasma glucose is the main determinant for the progression from impaired glucose tolerance to diabetes in Hong Kong Chinese.
      G T Ko, J K Li, A Y Cheung, V T Yeung, C C Chow, L W Tsang, C S Cockram and J C Chan
      Diabetes Care 1999 Dec; 22 (12): 2096-2097. https://doi.org/10.2337/diacare.22.12.2096

  10. Chwatko, G

    1. Total plasma homocysteine and insulin levels in type 2 diabetic patients with secondary failure to oral agents.
      J Drzewoski, L Czupryniak, G Chwatko and E Bald
      Diabetes Care 1999 Dec; 22 (12): 2097-2099. https://doi.org/10.2337/diacare.22.12.2097

  11. Clarke, W L

    1. Biopsychobehavioral model of severe hypoglycemia. II. Understanding the risk of severe hypoglycemia.
      D J Cox, L A Gonder-Frederick, B P Kovatchev, D L Young-Hyman, T W Donner, D M Julian and W L Clarke
      Diabetes Care 1999 Dec; 22 (12): 2018-2025. https://doi.org/10.2337/diacare.22.12.2018

  12. Cockram, C S

    1. Two-hour post-glucose loading plasma glucose is the main determinant for the progression from impaired glucose tolerance to diabetes in Hong Kong Chinese.
      G T Ko, J K Li, A Y Cheung, V T Yeung, C C Chow, L W Tsang, C S Cockram and J C Chan
      Diabetes Care 1999 Dec; 22 (12): 2096-2097. https://doi.org/10.2337/diacare.22.12.2096

  13. Cogswell, M E

    1. Diabetes and serum ferritin concentration among U.S. adults.
      E S Ford and M E Cogswell
      Diabetes Care 1999 Dec; 22 (12): 1978-1983. https://doi.org/10.2337/diacare.22.12.1978

  14. Colwell, G A

    1. Inflammation and diabetic vascular complications.
      G A Colwell
      Diabetes Care 1999 Dec; 22 (12): 1927-1928. https://doi.org/10.2337/diacare.22.12.1927

  15. Corcoy, R

    1. Benzodiazepine interruption. Does it cause hypoglycemia?
      A M Wägner, S M Webb and R Corcoy
      Diabetes Care 1999 Dec; 22 (12): 2099. https://doi.org/10.2337/diacare.22.12.2099b

  16. Costa, M

    1. Diabetes management in a health maintenance organization. Efficacy of care management using cluster visits.
      C N Sadur, N Moline, M Costa, D Michalik, D Mendlowitz, S Roller, R Watson, B E Swain, J V Selby and W C Javorski
      Diabetes Care 1999 Dec; 22 (12): 2011-2017. https://doi.org/10.2337/diacare.22.12.2011

  17. Couper, J J

    1. Failure to maintain the benefits of home-based intervention in adolescents with poorly controlled type 1 diabetes.
      J J Couper, J Taylor, M J Fotheringham and M Sawyer
      Diabetes Care 1999 Dec; 22 (12): 1933-1937. https://doi.org/10.2337/diacare.22.12.1933

  18. Cox, D J

    1. Biopsychobehavioral model of severe hypoglycemia. II. Understanding the risk of severe hypoglycemia.
      D J Cox, L A Gonder-Frederick, B P Kovatchev, D L Young-Hyman, T W Donner, D M Julian and W L Clarke
      Diabetes Care 1999 Dec; 22 (12): 2018-2025. https://doi.org/10.2337/diacare.22.12.2018

  19. Czupryniak, L

    1. Total plasma homocysteine and insulin levels in type 2 diabetic patients with secondary failure to oral agents.
      J Drzewoski, L Czupryniak, G Chwatko and E Bald
      Diabetes Care 1999 Dec; 22 (12): 2097-2099. https://doi.org/10.2337/diacare.22.12.2097

D

  1. Daniel, M

    1. Diabetes incidence in an Australian aboriginal population. An 8-year follow-up study.
      M Daniel, K G Rowley, R McDermott, A Mylvaganam and K O'Dea
      Diabetes Care 1999 Dec; 22 (12): 1993-1998. https://doi.org/10.2337/diacare.22.12.1993

  2. Doi, K

    1. Insulin-sensitive and insulin-resistant variants in nonobese Japanese type 2 diabetic patients. The role of triglycerides in insulin resistance.
      A Taniguchi, M Fukushima, M Sakai, K Kataoka, K Miwa, I Nagata, K Doi, K Tokuyama and Y Nakai
      Diabetes Care 1999 Dec; 22 (12): 2100-2101. https://doi.org/10.2337/diacare.22.12.2100

  3. Donner, T W

    1. Biopsychobehavioral model of severe hypoglycemia. II. Understanding the risk of severe hypoglycemia.
      D J Cox, L A Gonder-Frederick, B P Kovatchev, D L Young-Hyman, T W Donner, D M Julian and W L Clarke
      Diabetes Care 1999 Dec; 22 (12): 2018-2025. https://doi.org/10.2337/diacare.22.12.2018

  4. Drzewoski, J

    1. Total plasma homocysteine and insulin levels in type 2 diabetic patients with secondary failure to oral agents.
      J Drzewoski, L Czupryniak, G Chwatko and E Bald
      Diabetes Care 1999 Dec; 22 (12): 2097-2099. https://doi.org/10.2337/diacare.22.12.2097

  5. Dunger, D B

    1. Eating habits, body weight, and insulin misuse. A longitudinal study of teenagers and young adults with type 1 diabetes.
      K S Bryden, A Neil, R A Mayou, R C Peveler, C G Fairburn and D B Dunger
      Diabetes Care 1999 Dec; 22 (12): 1956-1960. https://doi.org/10.2337/diacare.22.12.1956

E

  1. Edmonds, M E

    1. Plantar pressures are elevated in the neuroischemic and the neuropathic diabetic foot.
      D L Pitei, M Lord, A Foster, S Wilson, P J Watkins and M E Edmonds
      Diabetes Care 1999 Dec; 22 (12): 1966-1970. https://doi.org/10.2337/diacare.22.12.1966

  2. Elian, N

    1. Safety of human insulin in poor-sighted elderly diabetic patients.
      J J Altman, N Elian, M Bonnemaire, S Calmar and S Feldman
      Diabetes Care 1999 Dec; 22 (12): 2089. https://doi.org/10.2337/diacare.22.12.2089b

F

  1. Fairburn, C G

    1. Eating habits, body weight, and insulin misuse. A longitudinal study of teenagers and young adults with type 1 diabetes.
      K S Bryden, A Neil, R A Mayou, R C Peveler, C G Fairburn and D B Dunger
      Diabetes Care 1999 Dec; 22 (12): 1956-1960. https://doi.org/10.2337/diacare.22.12.1956

  2. Feldman, S

    1. Safety of human insulin in poor-sighted elderly diabetic patients.
      J J Altman, N Elian, M Bonnemaire, S Calmar and S Feldman
      Diabetes Care 1999 Dec; 22 (12): 2089. https://doi.org/10.2337/diacare.22.12.2089b

  3. Fernlund, P

    1. Progression of retinopathy after improved metabolic control in type 2 diabetic patients. Relation to IGF-1 and hemostatic variables.
      M Henricsson, K Berntorp, E Berntorp, P Fernlund and G Sundkvist
      Diabetes Care 1999 Dec; 22 (12): 1944-1949. https://doi.org/10.2337/diacare.22.12.1944

  4. Ford, E S

    1. Body mass index, diabetes, and C-reactive protein among U.S. adults.
      E S Ford
      Diabetes Care 1999 Dec; 22 (12): 1971-1977. https://doi.org/10.2337/diacare.22.12.1971
    2. Diabetes and serum ferritin concentration among U.S. adults.
      E S Ford and M E Cogswell
      Diabetes Care 1999 Dec; 22 (12): 1978-1983. https://doi.org/10.2337/diacare.22.12.1978

  5. Forsen, T

    1. Neonatal anthropometric measurements and risk of childhood-onset type 1 diabetes. DiMe Study Group.
      T Podar, P Onkamo, T Forsen, M Karvonen, E Tuomilehto-Wolf and J Tuomilehto
      Diabetes Care 1999 Dec; 22 (12): 2092-2094. https://doi.org/10.2337/diacare.22.12.2092a

  6. Foster, A

    1. Plantar pressures are elevated in the neuroischemic and the neuropathic diabetic foot.
      D L Pitei, M Lord, A Foster, S Wilson, P J Watkins and M E Edmonds
      Diabetes Care 1999 Dec; 22 (12): 1966-1970. https://doi.org/10.2337/diacare.22.12.1966

  7. Fotheringham, M J

    1. Failure to maintain the benefits of home-based intervention in adolescents with poorly controlled type 1 diabetes.
      J J Couper, J Taylor, M J Fotheringham and M Sawyer
      Diabetes Care 1999 Dec; 22 (12): 1933-1937. https://doi.org/10.2337/diacare.22.12.1933

  8. Fujibayashi, K

    1. Troglitazone efficacy in a subject with glucocorticoid-induced diabetes.
      K Fujibayashi, S Nagasaka, N Itabashi, A Kawakami, T Nakamura, I Kusaka, S Ishikawa and T Saito
      Diabetes Care 1999 Dec; 22 (12): 2088-2089. https://doi.org/10.2337/diacare.22.12.2088

  9. Fukushima, M

    1. Insulin-sensitive and insulin-resistant variants in nonobese Japanese type 2 diabetic patients. The role of triglycerides in insulin resistance.
      A Taniguchi, M Fukushima, M Sakai, K Kataoka, K Miwa, I Nagata, K Doi, K Tokuyama and Y Nakai
      Diabetes Care 1999 Dec; 22 (12): 2100-2101. https://doi.org/10.2337/diacare.22.12.2100

  10. Fumelli, P

    1. Renal disease as a determinant of increased lipoprotein(a) concentrations in diabetic patients.
      M Boemi, C Sirolla, P Fumelli and R W James
      Diabetes Care 1999 Dec; 22 (12): 2033-2036. https://doi.org/10.2337/diacare.22.12.2033

G

  1. Gabriely, I

    1. Transcutaneous glucose measurement using near-infrared spectroscopy during hypoglycemia.
      I Gabriely, R Wozniak, M Mevorach, J Kaplan, Y Aharon and H Shamoon
      Diabetes Care 1999 Dec; 22 (12): 2026-2032. https://doi.org/10.2337/diacare.22.12.2026

  2. Gale, E A

    1. Progression to diabetes in relatives with islet autoantibodies. Is it inevitable?
      S G Gardner, E A Gale, A J Williams, K M Gillespie, K E Lawrence, G F Bottazzo and P J Bingley
      Diabetes Care 1999 Dec; 22 (12): 2049-2054. https://doi.org/10.2337/diacare.22.12.2049

  3. Gardner, S G

    1. Progression to diabetes in relatives with islet autoantibodies. Is it inevitable?
      S G Gardner, E A Gale, A J Williams, K M Gillespie, K E Lawrence, G F Bottazzo and P J Bingley
      Diabetes Care 1999 Dec; 22 (12): 2049-2054. https://doi.org/10.2337/diacare.22.12.2049

  4. Gattegno, L

    1. Soluble L-selectin level is a marker for coronary artery disease in type 2 diabetic patients.
      J P Albertini, P Valensi, B Lormeau, J Vaysse, J R Attali and L Gattegno
      Diabetes Care 1999 Dec; 22 (12): 2044-2048. https://doi.org/10.2337/diacare.22.12.2044

  5. Gentile, L

    1. Prevalence of patients reaching the targets of good control in normal clinical practice. A cohort-based study in type 2 diabetes.
      S Bo, P Cavallo-Perin and L Gentile
      Diabetes Care 1999 Dec; 22 (12): 2092. https://doi.org/10.2337/diacare.22.12.2092b

  6. Gillespie, K M

    1. Progression to diabetes in relatives with islet autoantibodies. Is it inevitable?
      S G Gardner, E A Gale, A J Williams, K M Gillespie, K E Lawrence, G F Bottazzo and P J Bingley
      Diabetes Care 1999 Dec; 22 (12): 2049-2054. https://doi.org/10.2337/diacare.22.12.2049

  7. Glasgow, R E

    1. In diabetes care, moving from compliance to adherence is not enough. Something entirely different is needed.
      R E Glasgow and R M Anderson
      Diabetes Care 1999 Dec; 22 (12): 2090-2092. https://doi.org/10.2337/diacare.22.12.2090

  8. Gonder-Frederick, L A

    1. Biopsychobehavioral model of severe hypoglycemia. II. Understanding the risk of severe hypoglycemia.
      D J Cox, L A Gonder-Frederick, B P Kovatchev, D L Young-Hyman, T W Donner, D M Julian and W L Clarke
      Diabetes Care 1999 Dec; 22 (12): 2018-2025. https://doi.org/10.2337/diacare.22.12.2018

  9. Grande, C

    1. Red blood cell autoantibodies with a shortened erythrocyte life span as a cause of lack of relation between glycosylated hemoglobin and mean blood glucose levels in a woman with type 1 diabetes.
      L Herranz, C Grande, M Janez and F Pallardo
      Diabetes Care 1999 Dec; 22 (12): 2085-2086. https://doi.org/10.2337/diacare.22.12.2085

  10. Groop, P H

    1. In vivo endothelial dysfunction characterizes patients with impaired fasting glucose.
      S Vehkavaara, A Seppälä-Lindroos, J Westerbacka, P H Groop and H Yki-Järvinen
      Diabetes Care 1999 Dec; 22 (12): 2055-2060. https://doi.org/10.2337/diacare.22.12.2055

H

  1. Hallmans, G

    1. Screening for impaired glucose tolerance. Results from a population-based study in 21,057 individuals.
      B Lindahl, L Weinehall, K Asplund and G Hallmans
      Diabetes Care 1999 Dec; 22 (12): 1988-1992. https://doi.org/10.2337/diacare.22.12.1988

  2. Hanley, A J

    1. Youth-onset type 2 diabetes (Y2DM) associated with HNF1A S319 in aboriginal Canadians.
      R A Hegele, A J Hanley, B Zinman, S B Harris and C M Anderson
      Diabetes Care 1999 Dec; 22 (12): 2095-2096. https://doi.org/10.2337/diacare.22.12.2095

  3. Harris, S B

    1. Youth-onset type 2 diabetes (Y2DM) associated with HNF1A S319 in aboriginal Canadians.
      R A Hegele, A J Hanley, B Zinman, S B Harris and C M Anderson
      Diabetes Care 1999 Dec; 22 (12): 2095-2096. https://doi.org/10.2337/diacare.22.12.2095

  4. Hegele, R A

    1. Youth-onset type 2 diabetes (Y2DM) associated with HNF1A S319 in aboriginal Canadians.
      R A Hegele, A J Hanley, B Zinman, S B Harris and C M Anderson
      Diabetes Care 1999 Dec; 22 (12): 2095-2096. https://doi.org/10.2337/diacare.22.12.2095

  5. Heine, R J

    1. The 12-item well-being questionnaire. An evaluation of its validity and reliability in Dutch people with diabetes.
      F Pouwer, H M van der Ploeg, H J Adèr, R J Heine and F J Snoek
      Diabetes Care 1999 Dec; 22 (12): 2004-2010. https://doi.org/10.2337/diacare.22.12.2004

  6. Henricsson, M

    1. Progression of retinopathy after improved metabolic control in type 2 diabetic patients. Relation to IGF-1 and hemostatic variables.
      M Henricsson, K Berntorp, E Berntorp, P Fernlund and G Sundkvist
      Diabetes Care 1999 Dec; 22 (12): 1944-1949. https://doi.org/10.2337/diacare.22.12.1944

  7. Herranz, L

    1. Red blood cell autoantibodies with a shortened erythrocyte life span as a cause of lack of relation between glycosylated hemoglobin and mean blood glucose levels in a woman with type 1 diabetes.
      L Herranz, C Grande, M Janez and F Pallardo
      Diabetes Care 1999 Dec; 22 (12): 2085-2086. https://doi.org/10.2337/diacare.22.12.2085

  8. Hori, M

    1. Impaired diurnal cardiac autonomic function in subjects with type 2 diabetes.
      M Yamamoto, Y Yamasaki, M Kodama, M Matsuhisa, M Kishimoto, H Ozaki, A Tani, N Ueda, M Iwasaki and M Hori
      Diabetes Care 1999 Dec; 22 (12): 2072-2077. https://doi.org/10.2337/diacare.22.12.2072

  9. Horsten, M

    1. Education and the metabolic syndrome in women.
      S P Wamala, J Lynch, M Horsten, M A Mittleman, K Schenck-Gustafsson and K Orth-Gomér
      Diabetes Care 1999 Dec; 22 (12): 1999-2003. https://doi.org/10.2337/diacare.22.12.1999

  10. Hyöty, H

    1. Enterovirus antibodies in relation to islet cell antibodies in two populations with high and low incidence of type 1 diabetes.
      M Lönnrot, M Knip, D Marciulionyte, J Rahko, B Urbonaite, W P Moore, P Vilja and H Hyöty
      Diabetes Care 1999 Dec; 22 (12): 2086-2088. https://doi.org/10.2337/diacare.22.12.2086

  11. Hyppönen, E

    1. Infant feeding, early weight gain, and risk of type 1 diabetes. Childhood Diabetes in Finland (DiMe) Study Group.
      E Hyppönen, M G Kenward, S M Virtanen, A Piitulainen, P Virta-Autio, J Tuomilehto, M Knip and H K Akerblom
      Diabetes Care 1999 Dec; 22 (12): 1961-1965. https://doi.org/10.2337/diacare.22.12.1961

I

  1. Ikegami, H

    1. All patients with Werner's syndrome are insulin resistant, but only those who also have impaired insulin secretion develop overt diabetes.
      K Yamada, H Ikegami, H Yoneda, T Miki and T Ogihara
      Diabetes Care 1999 Dec; 22 (12): 2094-2095. https://doi.org/10.2337/diacare.22.12.2094

  2. Ilonen, J

    1. Clinical, autoimmune, and genetic characteristics of very young children with type 1 diabetes. Childhood Diabetes in Finland (DiMe) Study Group.
      J Komulainen, P Kulmala, K Savola, R Lounamaa, J Ilonen, H Reijonen, M Knip and H K Akerblom
      Diabetes Care 1999 Dec; 22 (12): 1950-1955. https://doi.org/10.2337/diacare.22.12.1950

  3. Ishikawa, S

    1. Troglitazone efficacy in a subject with glucocorticoid-induced diabetes.
      K Fujibayashi, S Nagasaka, N Itabashi, A Kawakami, T Nakamura, I Kusaka, S Ishikawa and T Saito
      Diabetes Care 1999 Dec; 22 (12): 2088-2089. https://doi.org/10.2337/diacare.22.12.2088

  4. Itabashi, N

    1. Troglitazone efficacy in a subject with glucocorticoid-induced diabetes.
      K Fujibayashi, S Nagasaka, N Itabashi, A Kawakami, T Nakamura, I Kusaka, S Ishikawa and T Saito
      Diabetes Care 1999 Dec; 22 (12): 2088-2089. https://doi.org/10.2337/diacare.22.12.2088

  5. Ito, M K

    1. A drug interaction between troglitazone and simvastatin.
      J C Lin and M K Ito
      Diabetes Care 1999 Dec; 22 (12): 2104-2106. https://doi.org/10.2337/diacare.22.12.2104a

  6. Iwasaki, M

    1. Impaired diurnal cardiac autonomic function in subjects with type 2 diabetes.
      M Yamamoto, Y Yamasaki, M Kodama, M Matsuhisa, M Kishimoto, H Ozaki, A Tani, N Ueda, M Iwasaki and M Hori
      Diabetes Care 1999 Dec; 22 (12): 2072-2077. https://doi.org/10.2337/diacare.22.12.2072

J

  1. James, R W

    1. Renal disease as a determinant of increased lipoprotein(a) concentrations in diabetic patients.
      M Boemi, C Sirolla, P Fumelli and R W James
      Diabetes Care 1999 Dec; 22 (12): 2033-2036. https://doi.org/10.2337/diacare.22.12.2033

  2. Janez, M

    1. Red blood cell autoantibodies with a shortened erythrocyte life span as a cause of lack of relation between glycosylated hemoglobin and mean blood glucose levels in a woman with type 1 diabetes.
      L Herranz, C Grande, M Janez and F Pallardo
      Diabetes Care 1999 Dec; 22 (12): 2085-2086. https://doi.org/10.2337/diacare.22.12.2085

  3. Jansen, H

    1. Lack of effect on LDL oxidation and antioxidant status after improvement of metabolic control in type 2 diabetes.
      W A Oranje, G J Rondas-Colbers, G N Swennen, H Jansen and B H Wolffenbuttel
      Diabetes Care 1999 Dec; 22 (12): 2083-2084. https://doi.org/10.2337/diacare.22.12.2083

  4. Javorski, W C

    1. Diabetes management in a health maintenance organization. Efficacy of care management using cluster visits.
      C N Sadur, N Moline, M Costa, D Michalik, D Mendlowitz, S Roller, R Watson, B E Swain, J V Selby and W C Javorski
      Diabetes Care 1999 Dec; 22 (12): 2011-2017. https://doi.org/10.2337/diacare.22.12.2011

  5. Jick, S S

    1. Frequency of liver disease in type 2 diabetic patients treated with oral antidiabetic agents.
      S S Jick, M Stender and M W Myers
      Diabetes Care 1999 Dec; 22 (12): 2067-2071. https://doi.org/10.2337/diacare.22.12.2067

  6. Johnston, G D

    1. Relationship of endothelial function to birth weight in humans.
      A S McAllister, A B Atkinson, G D Johnston and D R McCance
      Diabetes Care 1999 Dec; 22 (12): 2061-2066. https://doi.org/10.2337/diacare.22.12.2061

  7. Julian, D M

    1. Biopsychobehavioral model of severe hypoglycemia. II. Understanding the risk of severe hypoglycemia.
      D J Cox, L A Gonder-Frederick, B P Kovatchev, D L Young-Hyman, T W Donner, D M Julian and W L Clarke
      Diabetes Care 1999 Dec; 22 (12): 2018-2025. https://doi.org/10.2337/diacare.22.12.2018

K

  1. Kaplan, J

    1. Transcutaneous glucose measurement using near-infrared spectroscopy during hypoglycemia.
      I Gabriely, R Wozniak, M Mevorach, J Kaplan, Y Aharon and H Shamoon
      Diabetes Care 1999 Dec; 22 (12): 2026-2032. https://doi.org/10.2337/diacare.22.12.2026

  2. Karvonen, M

    1. Neonatal anthropometric measurements and risk of childhood-onset type 1 diabetes. DiMe Study Group.
      T Podar, P Onkamo, T Forsen, M Karvonen, E Tuomilehto-Wolf and J Tuomilehto
      Diabetes Care 1999 Dec; 22 (12): 2092-2094. https://doi.org/10.2337/diacare.22.12.2092a

  3. Kataoka, K

    1. Insulin-sensitive and insulin-resistant variants in nonobese Japanese type 2 diabetic patients. The role of triglycerides in insulin resistance.
      A Taniguchi, M Fukushima, M Sakai, K Kataoka, K Miwa, I Nagata, K Doi, K Tokuyama and Y Nakai
      Diabetes Care 1999 Dec; 22 (12): 2100-2101. https://doi.org/10.2337/diacare.22.12.2100

  4. Kawakami, A

    1. Troglitazone efficacy in a subject with glucocorticoid-induced diabetes.
      K Fujibayashi, S Nagasaka, N Itabashi, A Kawakami, T Nakamura, I Kusaka, S Ishikawa and T Saito
      Diabetes Care 1999 Dec; 22 (12): 2088-2089. https://doi.org/10.2337/diacare.22.12.2088

  5. Kenward, M G

    1. Infant feeding, early weight gain, and risk of type 1 diabetes. Childhood Diabetes in Finland (DiMe) Study Group.
      E Hyppönen, M G Kenward, S M Virtanen, A Piitulainen, P Virta-Autio, J Tuomilehto, M Knip and H K Akerblom
      Diabetes Care 1999 Dec; 22 (12): 1961-1965. https://doi.org/10.2337/diacare.22.12.1961

  6. Kishimoto, M

    1. Impaired diurnal cardiac autonomic function in subjects with type 2 diabetes.
      M Yamamoto, Y Yamasaki, M Kodama, M Matsuhisa, M Kishimoto, H Ozaki, A Tani, N Ueda, M Iwasaki and M Hori
      Diabetes Care 1999 Dec; 22 (12): 2072-2077. https://doi.org/10.2337/diacare.22.12.2072

  7. Klein, B E

    1. Exogenous estrogen exposures and changes in diabetic retinopathy. The Wisconsin Epidemiologic Study of Diabetic Retinopathy.
      B E Klein, R Klein and S E Moss
      Diabetes Care 1999 Dec; 22 (12): 1984-1987. https://doi.org/10.2337/diacare.22.12.1984

  8. Klein, R

    1. Exogenous estrogen exposures and changes in diabetic retinopathy. The Wisconsin Epidemiologic Study of Diabetic Retinopathy.
      B E Klein, R Klein and S E Moss
      Diabetes Care 1999 Dec; 22 (12): 1984-1987. https://doi.org/10.2337/diacare.22.12.1984

  9. Knip, M

    1. Clinical, autoimmune, and genetic characteristics of very young children with type 1 diabetes. Childhood Diabetes in Finland (DiMe) Study Group.
      J Komulainen, P Kulmala, K Savola, R Lounamaa, J Ilonen, H Reijonen, M Knip and H K Akerblom
      Diabetes Care 1999 Dec; 22 (12): 1950-1955. https://doi.org/10.2337/diacare.22.12.1950
    2. Infant feeding, early weight gain, and risk of type 1 diabetes. Childhood Diabetes in Finland (DiMe) Study Group.
      E Hyppönen, M G Kenward, S M Virtanen, A Piitulainen, P Virta-Autio, J Tuomilehto, M Knip and H K Akerblom
      Diabetes Care 1999 Dec; 22 (12): 1961-1965. https://doi.org/10.2337/diacare.22.12.1961
    3. Enterovirus antibodies in relation to islet cell antibodies in two populations with high and low incidence of type 1 diabetes.
      M Lönnrot, M Knip, D Marciulionyte, J Rahko, B Urbonaite, W P Moore, P Vilja and H Hyöty
      Diabetes Care 1999 Dec; 22 (12): 2086-2088. https://doi.org/10.2337/diacare.22.12.2086

  10. Ko, G T

    1. Two-hour post-glucose loading plasma glucose is the main determinant for the progression from impaired glucose tolerance to diabetes in Hong Kong Chinese.
      G T Ko, J K Li, A Y Cheung, V T Yeung, C C Chow, L W Tsang, C S Cockram and J C Chan
      Diabetes Care 1999 Dec; 22 (12): 2096-2097. https://doi.org/10.2337/diacare.22.12.2096

  11. Kodama, M

    1. Impaired diurnal cardiac autonomic function in subjects with type 2 diabetes.
      M Yamamoto, Y Yamasaki, M Kodama, M Matsuhisa, M Kishimoto, H Ozaki, A Tani, N Ueda, M Iwasaki and M Hori
      Diabetes Care 1999 Dec; 22 (12): 2072-2077. https://doi.org/10.2337/diacare.22.12.2072

  12. Komulainen, J

    1. Clinical, autoimmune, and genetic characteristics of very young children with type 1 diabetes. Childhood Diabetes in Finland (DiMe) Study Group.
      J Komulainen, P Kulmala, K Savola, R Lounamaa, J Ilonen, H Reijonen, M Knip and H K Akerblom
      Diabetes Care 1999 Dec; 22 (12): 1950-1955. https://doi.org/10.2337/diacare.22.12.1950

  13. Kovatchev, B P

    1. Biopsychobehavioral model of severe hypoglycemia. II. Understanding the risk of severe hypoglycemia.
      D J Cox, L A Gonder-Frederick, B P Kovatchev, D L Young-Hyman, T W Donner, D M Julian and W L Clarke
      Diabetes Care 1999 Dec; 22 (12): 2018-2025. https://doi.org/10.2337/diacare.22.12.2018

  14. Kulmala, P

    1. Clinical, autoimmune, and genetic characteristics of very young children with type 1 diabetes. Childhood Diabetes in Finland (DiMe) Study Group.
      J Komulainen, P Kulmala, K Savola, R Lounamaa, J Ilonen, H Reijonen, M Knip and H K Akerblom
      Diabetes Care 1999 Dec; 22 (12): 1950-1955. https://doi.org/10.2337/diacare.22.12.1950

  15. Kusaka, I

    1. Troglitazone efficacy in a subject with glucocorticoid-induced diabetes.
      K Fujibayashi, S Nagasaka, N Itabashi, A Kawakami, T Nakamura, I Kusaka, S Ishikawa and T Saito
      Diabetes Care 1999 Dec; 22 (12): 2088-2089. https://doi.org/10.2337/diacare.22.12.2088

L

  1. Lawrence, K E

    1. Progression to diabetes in relatives with islet autoantibodies. Is it inevitable?
      S G Gardner, E A Gale, A J Williams, K M Gillespie, K E Lawrence, G F Bottazzo and P J Bingley
      Diabetes Care 1999 Dec; 22 (12): 2049-2054. https://doi.org/10.2337/diacare.22.12.2049

  2. Li, J K

    1. Two-hour post-glucose loading plasma glucose is the main determinant for the progression from impaired glucose tolerance to diabetes in Hong Kong Chinese.
      G T Ko, J K Li, A Y Cheung, V T Yeung, C C Chow, L W Tsang, C S Cockram and J C Chan
      Diabetes Care 1999 Dec; 22 (12): 2096-2097. https://doi.org/10.2337/diacare.22.12.2096

  3. Lin, J C

    1. A drug interaction between troglitazone and simvastatin.
      J C Lin and M K Ito
      Diabetes Care 1999 Dec; 22 (12): 2104-2106. https://doi.org/10.2337/diacare.22.12.2104a

  4. Lindahl, B

    1. Screening for impaired glucose tolerance. Results from a population-based study in 21,057 individuals.
      B Lindahl, L Weinehall, K Asplund and G Hallmans
      Diabetes Care 1999 Dec; 22 (12): 1988-1992. https://doi.org/10.2337/diacare.22.12.1988

  5. Lipsky, M S

    1. The short-term impact of a continuing medical education program on providers' attitudes toward treating diabetes.
      L K Sharp and M S Lipsky
      Diabetes Care 1999 Dec; 22 (12): 1929-1932. https://doi.org/10.2337/diacare.22.12.1929

  6. Lizzio, S

    1. Meal-generated oxidative stress in diabetes. The protective effect of red wine.
      A Ceriello, N Bortolotti, E Motz, S Lizzio, A Russo, V Selmo, B Catone, L Tonutti and C Taboga
      Diabetes Care 1999 Dec; 22 (12): 2084-2085. https://doi.org/10.2337/diacare.22.12.2084

  7. Loi, CM

    1. Response to Lin and Ito. Effect of troglitazone on atorvastatin pharmacokinetics and pharmacodynamics
      CM Loi and AJ Sedman
      Diabetes Care 1999 Dec; 22 (12): 2105-2106. https://doi.org/10.2337/diacare.22.12.2105

  8. Lönnrot, M

    1. Enterovirus antibodies in relation to islet cell antibodies in two populations with high and low incidence of type 1 diabetes.
      M Lönnrot, M Knip, D Marciulionyte, J Rahko, B Urbonaite, W P Moore, P Vilja and H Hyöty
      Diabetes Care 1999 Dec; 22 (12): 2086-2088. https://doi.org/10.2337/diacare.22.12.2086

  9. Lord, M

    1. Plantar pressures are elevated in the neuroischemic and the neuropathic diabetic foot.
      D L Pitei, M Lord, A Foster, S Wilson, P J Watkins and M E Edmonds
      Diabetes Care 1999 Dec; 22 (12): 1966-1970. https://doi.org/10.2337/diacare.22.12.1966

  10. Lormeau, B

    1. Soluble L-selectin level is a marker for coronary artery disease in type 2 diabetic patients.
      J P Albertini, P Valensi, B Lormeau, J Vaysse, J R Attali and L Gattegno
      Diabetes Care 1999 Dec; 22 (12): 2044-2048. https://doi.org/10.2337/diacare.22.12.2044

  11. Lounamaa, R

    1. Clinical, autoimmune, and genetic characteristics of very young children with type 1 diabetes. Childhood Diabetes in Finland (DiMe) Study Group.
      J Komulainen, P Kulmala, K Savola, R Lounamaa, J Ilonen, H Reijonen, M Knip and H K Akerblom
      Diabetes Care 1999 Dec; 22 (12): 1950-1955. https://doi.org/10.2337/diacare.22.12.1950

  12. Lu, F H

    1. Discriminating glucose tolerance status by regions of interest of dual-energy X-ray absorptiometry. Clinical implications of body fat distribution.
      C J Chang, C H Wu, F H Lu, J S Wu, N T Chiu and W J Yao
      Diabetes Care 1999 Dec; 22 (12): 1938-1943. https://doi.org/10.2337/diacare.22.12.1938

  13. Lynch, J

    1. Education and the metabolic syndrome in women.
      S P Wamala, J Lynch, M Horsten, M A Mittleman, K Schenck-Gustafsson and K Orth-Gomér
      Diabetes Care 1999 Dec; 22 (12): 1999-2003. https://doi.org/10.2337/diacare.22.12.1999

M

  1. Marciulionyte, D

    1. Enterovirus antibodies in relation to islet cell antibodies in two populations with high and low incidence of type 1 diabetes.
      M Lönnrot, M Knip, D Marciulionyte, J Rahko, B Urbonaite, W P Moore, P Vilja and H Hyöty
      Diabetes Care 1999 Dec; 22 (12): 2086-2088. https://doi.org/10.2337/diacare.22.12.2086

  2. Matsuhisa, M

    1. Impaired diurnal cardiac autonomic function in subjects with type 2 diabetes.
      M Yamamoto, Y Yamasaki, M Kodama, M Matsuhisa, M Kishimoto, H Ozaki, A Tani, N Ueda, M Iwasaki and M Hori
      Diabetes Care 1999 Dec; 22 (12): 2072-2077. https://doi.org/10.2337/diacare.22.12.2072

  3. Mayou, R A

    1. Eating habits, body weight, and insulin misuse. A longitudinal study of teenagers and young adults with type 1 diabetes.
      K S Bryden, A Neil, R A Mayou, R C Peveler, C G Fairburn and D B Dunger
      Diabetes Care 1999 Dec; 22 (12): 1956-1960. https://doi.org/10.2337/diacare.22.12.1956

  4. McAllister, A S

    1. Relationship of endothelial function to birth weight in humans.
      A S McAllister, A B Atkinson, G D Johnston and D R McCance
      Diabetes Care 1999 Dec; 22 (12): 2061-2066. https://doi.org/10.2337/diacare.22.12.2061

  5. McCance, D R

    1. Relationship of endothelial function to birth weight in humans.
      A S McAllister, A B Atkinson, G D Johnston and D R McCance
      Diabetes Care 1999 Dec; 22 (12): 2061-2066. https://doi.org/10.2337/diacare.22.12.2061

  6. McDermott, R

    1. Diabetes incidence in an Australian aboriginal population. An 8-year follow-up study.
      M Daniel, K G Rowley, R McDermott, A Mylvaganam and K O'Dea
      Diabetes Care 1999 Dec; 22 (12): 1993-1998. https://doi.org/10.2337/diacare.22.12.1993

  7. Melki, V

    1. Assessment of in vivo stability of a new insulin preparation for implantable insulin pumps. A randomized multicenter prospective trial. EVADIAC Group. Evaluation Dans le diabète du Traitement par Implants Actifs.
      S Boivin, P Belicar and V Melki
      Diabetes Care 1999 Dec; 22 (12): 2089-2090. https://doi.org/10.2337/diacare.22.12.2089a

  8. Mendlowitz, D

    1. Diabetes management in a health maintenance organization. Efficacy of care management using cluster visits.
      C N Sadur, N Moline, M Costa, D Michalik, D Mendlowitz, S Roller, R Watson, B E Swain, J V Selby and W C Javorski
      Diabetes Care 1999 Dec; 22 (12): 2011-2017. https://doi.org/10.2337/diacare.22.12.2011

  9. Mevorach, M

    1. Transcutaneous glucose measurement using near-infrared spectroscopy during hypoglycemia.
      I Gabriely, R Wozniak, M Mevorach, J Kaplan, Y Aharon and H Shamoon
      Diabetes Care 1999 Dec; 22 (12): 2026-2032. https://doi.org/10.2337/diacare.22.12.2026

  10. Michalik, D

    1. Diabetes management in a health maintenance organization. Efficacy of care management using cluster visits.
      C N Sadur, N Moline, M Costa, D Michalik, D Mendlowitz, S Roller, R Watson, B E Swain, J V Selby and W C Javorski
      Diabetes Care 1999 Dec; 22 (12): 2011-2017. https://doi.org/10.2337/diacare.22.12.2011

  11. Miki, T

    1. All patients with Werner's syndrome are insulin resistant, but only those who also have impaired insulin secretion develop overt diabetes.
      K Yamada, H Ikegami, H Yoneda, T Miki and T Ogihara
      Diabetes Care 1999 Dec; 22 (12): 2094-2095. https://doi.org/10.2337/diacare.22.12.2094

  12. Mittleman, M A

    1. Education and the metabolic syndrome in women.
      S P Wamala, J Lynch, M Horsten, M A Mittleman, K Schenck-Gustafsson and K Orth-Gomér
      Diabetes Care 1999 Dec; 22 (12): 1999-2003. https://doi.org/10.2337/diacare.22.12.1999

  13. Miwa, K

    1. Insulin-sensitive and insulin-resistant variants in nonobese Japanese type 2 diabetic patients. The role of triglycerides in insulin resistance.
      A Taniguchi, M Fukushima, M Sakai, K Kataoka, K Miwa, I Nagata, K Doi, K Tokuyama and Y Nakai
      Diabetes Care 1999 Dec; 22 (12): 2100-2101. https://doi.org/10.2337/diacare.22.12.2100

  14. Moline, N

    1. Diabetes management in a health maintenance organization. Efficacy of care management using cluster visits.
      C N Sadur, N Moline, M Costa, D Michalik, D Mendlowitz, S Roller, R Watson, B E Swain, J V Selby and W C Javorski
      Diabetes Care 1999 Dec; 22 (12): 2011-2017. https://doi.org/10.2337/diacare.22.12.2011

  15. Moore, W P

    1. Enterovirus antibodies in relation to islet cell antibodies in two populations with high and low incidence of type 1 diabetes.
      M Lönnrot, M Knip, D Marciulionyte, J Rahko, B Urbonaite, W P Moore, P Vilja and H Hyöty
      Diabetes Care 1999 Dec; 22 (12): 2086-2088. https://doi.org/10.2337/diacare.22.12.2086

  16. Moss, S E

    1. Exogenous estrogen exposures and changes in diabetic retinopathy. The Wisconsin Epidemiologic Study of Diabetic Retinopathy.
      B E Klein, R Klein and S E Moss
      Diabetes Care 1999 Dec; 22 (12): 1984-1987. https://doi.org/10.2337/diacare.22.12.1984

  17. Motz, E

    1. Meal-generated oxidative stress in diabetes. The protective effect of red wine.
      A Ceriello, N Bortolotti, E Motz, S Lizzio, A Russo, V Selmo, B Catone, L Tonutti and C Taboga
      Diabetes Care 1999 Dec; 22 (12): 2084-2085. https://doi.org/10.2337/diacare.22.12.2084

  18. Myers, M W

    1. Frequency of liver disease in type 2 diabetic patients treated with oral antidiabetic agents.
      S S Jick, M Stender and M W Myers
      Diabetes Care 1999 Dec; 22 (12): 2067-2071. https://doi.org/10.2337/diacare.22.12.2067

  19. Mylvaganam, A

    1. Diabetes incidence in an Australian aboriginal population. An 8-year follow-up study.
      M Daniel, K G Rowley, R McDermott, A Mylvaganam and K O'Dea
      Diabetes Care 1999 Dec; 22 (12): 1993-1998. https://doi.org/10.2337/diacare.22.12.1993

N

  1. Nagasaka, S

    1. Troglitazone efficacy in a subject with glucocorticoid-induced diabetes.
      K Fujibayashi, S Nagasaka, N Itabashi, A Kawakami, T Nakamura, I Kusaka, S Ishikawa and T Saito
      Diabetes Care 1999 Dec; 22 (12): 2088-2089. https://doi.org/10.2337/diacare.22.12.2088

  2. Nagata, I

    1. Insulin-sensitive and insulin-resistant variants in nonobese Japanese type 2 diabetic patients. The role of triglycerides in insulin resistance.
      A Taniguchi, M Fukushima, M Sakai, K Kataoka, K Miwa, I Nagata, K Doi, K Tokuyama and Y Nakai
      Diabetes Care 1999 Dec; 22 (12): 2100-2101. https://doi.org/10.2337/diacare.22.12.2100

  3. Nakai, Y

    1. Insulin-sensitive and insulin-resistant variants in nonobese Japanese type 2 diabetic patients. The role of triglycerides in insulin resistance.
      A Taniguchi, M Fukushima, M Sakai, K Kataoka, K Miwa, I Nagata, K Doi, K Tokuyama and Y Nakai
      Diabetes Care 1999 Dec; 22 (12): 2100-2101. https://doi.org/10.2337/diacare.22.12.2100

  4. Nakamura, T

    1. Troglitazone efficacy in a subject with glucocorticoid-induced diabetes.
      K Fujibayashi, S Nagasaka, N Itabashi, A Kawakami, T Nakamura, I Kusaka, S Ishikawa and T Saito
      Diabetes Care 1999 Dec; 22 (12): 2088-2089. https://doi.org/10.2337/diacare.22.12.2088

  5. Neil, A

    1. Eating habits, body weight, and insulin misuse. A longitudinal study of teenagers and young adults with type 1 diabetes.
      K S Bryden, A Neil, R A Mayou, R C Peveler, C G Fairburn and D B Dunger
      Diabetes Care 1999 Dec; 22 (12): 1956-1960. https://doi.org/10.2337/diacare.22.12.1956

O

  1. O'Dea, K

    1. Diabetes incidence in an Australian aboriginal population. An 8-year follow-up study.
      M Daniel, K G Rowley, R McDermott, A Mylvaganam and K O'Dea
      Diabetes Care 1999 Dec; 22 (12): 1993-1998. https://doi.org/10.2337/diacare.22.12.1993

  2. Ogihara, T

    1. All patients with Werner's syndrome are insulin resistant, but only those who also have impaired insulin secretion develop overt diabetes.
      K Yamada, H Ikegami, H Yoneda, T Miki and T Ogihara
      Diabetes Care 1999 Dec; 22 (12): 2094-2095. https://doi.org/10.2337/diacare.22.12.2094

  3. Onkamo, P

    1. Neonatal anthropometric measurements and risk of childhood-onset type 1 diabetes. DiMe Study Group.
      T Podar, P Onkamo, T Forsen, M Karvonen, E Tuomilehto-Wolf and J Tuomilehto
      Diabetes Care 1999 Dec; 22 (12): 2092-2094. https://doi.org/10.2337/diacare.22.12.2092a

  4. Oranje, W A

    1. Lack of effect on LDL oxidation and antioxidant status after improvement of metabolic control in type 2 diabetes.
      W A Oranje, G J Rondas-Colbers, G N Swennen, H Jansen and B H Wolffenbuttel
      Diabetes Care 1999 Dec; 22 (12): 2083-2084. https://doi.org/10.2337/diacare.22.12.2083

  5. Orth-Gomér, K

    1. Education and the metabolic syndrome in women.
      S P Wamala, J Lynch, M Horsten, M A Mittleman, K Schenck-Gustafsson and K Orth-Gomér
      Diabetes Care 1999 Dec; 22 (12): 1999-2003. https://doi.org/10.2337/diacare.22.12.1999

  6. Ozaki, H

    1. Impaired diurnal cardiac autonomic function in subjects with type 2 diabetes.
      M Yamamoto, Y Yamasaki, M Kodama, M Matsuhisa, M Kishimoto, H Ozaki, A Tani, N Ueda, M Iwasaki and M Hori
      Diabetes Care 1999 Dec; 22 (12): 2072-2077. https://doi.org/10.2337/diacare.22.12.2072

P

  1. Pallardo, F

    1. Red blood cell autoantibodies with a shortened erythrocyte life span as a cause of lack of relation between glycosylated hemoglobin and mean blood glucose levels in a woman with type 1 diabetes.
      L Herranz, C Grande, M Janez and F Pallardo
      Diabetes Care 1999 Dec; 22 (12): 2085-2086. https://doi.org/10.2337/diacare.22.12.2085

  2. Peveler, R C

    1. Eating habits, body weight, and insulin misuse. A longitudinal study of teenagers and young adults with type 1 diabetes.
      K S Bryden, A Neil, R A Mayou, R C Peveler, C G Fairburn and D B Dunger
      Diabetes Care 1999 Dec; 22 (12): 1956-1960. https://doi.org/10.2337/diacare.22.12.1956

  3. Piitulainen, A

    1. Infant feeding, early weight gain, and risk of type 1 diabetes. Childhood Diabetes in Finland (DiMe) Study Group.
      E Hyppönen, M G Kenward, S M Virtanen, A Piitulainen, P Virta-Autio, J Tuomilehto, M Knip and H K Akerblom
      Diabetes Care 1999 Dec; 22 (12): 1961-1965. https://doi.org/10.2337/diacare.22.12.1961

  4. Pinzur, M S

    1. American Orthopaedic Foot and Ankle Society diabetic shoe survey.
      M S Pinzur
      Diabetes Care 1999 Dec; 22 (12): 2099-2100. https://doi.org/10.2337/diacare.22.12.2099a

  5. Pitei, D L

    1. Plantar pressures are elevated in the neuroischemic and the neuropathic diabetic foot.
      D L Pitei, M Lord, A Foster, S Wilson, P J Watkins and M E Edmonds
      Diabetes Care 1999 Dec; 22 (12): 1966-1970. https://doi.org/10.2337/diacare.22.12.1966

  6. Podar, T

    1. Neonatal anthropometric measurements and risk of childhood-onset type 1 diabetes. DiMe Study Group.
      T Podar, P Onkamo, T Forsen, M Karvonen, E Tuomilehto-Wolf and J Tuomilehto
      Diabetes Care 1999 Dec; 22 (12): 2092-2094. https://doi.org/10.2337/diacare.22.12.2092a

  7. Pouwer, F

    1. The 12-item well-being questionnaire. An evaluation of its validity and reliability in Dutch people with diabetes.
      F Pouwer, H M van der Ploeg, H J Adèr, R J Heine and F J Snoek
      Diabetes Care 1999 Dec; 22 (12): 2004-2010. https://doi.org/10.2337/diacare.22.12.2004

R

  1. Rahko, J

    1. Enterovirus antibodies in relation to islet cell antibodies in two populations with high and low incidence of type 1 diabetes.
      M Lönnrot, M Knip, D Marciulionyte, J Rahko, B Urbonaite, W P Moore, P Vilja and H Hyöty
      Diabetes Care 1999 Dec; 22 (12): 2086-2088. https://doi.org/10.2337/diacare.22.12.2086

  2. Rassam, A G

    1. Low-dose ethanol predisposes elderly fasted patients with type 2 diabetes to sulfonylurea-induced low blood glucose.
      M R Burge, T M Zeise, T A Sobhy, A G Rassam and D S Schade
      Diabetes Care 1999 Dec; 22 (12): 2037-2043. https://doi.org/10.2337/diacare.22.12.2037

  3. Reijonen, H

    1. Clinical, autoimmune, and genetic characteristics of very young children with type 1 diabetes. Childhood Diabetes in Finland (DiMe) Study Group.
      J Komulainen, P Kulmala, K Savola, R Lounamaa, J Ilonen, H Reijonen, M Knip and H K Akerblom
      Diabetes Care 1999 Dec; 22 (12): 1950-1955. https://doi.org/10.2337/diacare.22.12.1950

  4. Roller, S

    1. Diabetes management in a health maintenance organization. Efficacy of care management using cluster visits.
      C N Sadur, N Moline, M Costa, D Michalik, D Mendlowitz, S Roller, R Watson, B E Swain, J V Selby and W C Javorski
      Diabetes Care 1999 Dec; 22 (12): 2011-2017. https://doi.org/10.2337/diacare.22.12.2011

  5. Rondas-Colbers, G J

    1. Lack of effect on LDL oxidation and antioxidant status after improvement of metabolic control in type 2 diabetes.
      W A Oranje, G J Rondas-Colbers, G N Swennen, H Jansen and B H Wolffenbuttel
      Diabetes Care 1999 Dec; 22 (12): 2083-2084. https://doi.org/10.2337/diacare.22.12.2083

  6. Rowley, K G

    1. Diabetes incidence in an Australian aboriginal population. An 8-year follow-up study.
      M Daniel, K G Rowley, R McDermott, A Mylvaganam and K O'Dea
      Diabetes Care 1999 Dec; 22 (12): 1993-1998. https://doi.org/10.2337/diacare.22.12.1993

  7. Russo, A

    1. Meal-generated oxidative stress in diabetes. The protective effect of red wine.
      A Ceriello, N Bortolotti, E Motz, S Lizzio, A Russo, V Selmo, B Catone, L Tonutti and C Taboga
      Diabetes Care 1999 Dec; 22 (12): 2084-2085. https://doi.org/10.2337/diacare.22.12.2084

S

  1. Sadur, C N

    1. Diabetes management in a health maintenance organization. Efficacy of care management using cluster visits.
      C N Sadur, N Moline, M Costa, D Michalik, D Mendlowitz, S Roller, R Watson, B E Swain, J V Selby and W C Javorski
      Diabetes Care 1999 Dec; 22 (12): 2011-2017. https://doi.org/10.2337/diacare.22.12.2011

  2. Saito, T

    1. Troglitazone efficacy in a subject with glucocorticoid-induced diabetes.
      K Fujibayashi, S Nagasaka, N Itabashi, A Kawakami, T Nakamura, I Kusaka, S Ishikawa and T Saito
      Diabetes Care 1999 Dec; 22 (12): 2088-2089. https://doi.org/10.2337/diacare.22.12.2088

  3. Sakai, M

    1. Insulin-sensitive and insulin-resistant variants in nonobese Japanese type 2 diabetic patients. The role of triglycerides in insulin resistance.
      A Taniguchi, M Fukushima, M Sakai, K Kataoka, K Miwa, I Nagata, K Doi, K Tokuyama and Y Nakai
      Diabetes Care 1999 Dec; 22 (12): 2100-2101. https://doi.org/10.2337/diacare.22.12.2100

  4. Savola, K

    1. Clinical, autoimmune, and genetic characteristics of very young children with type 1 diabetes. Childhood Diabetes in Finland (DiMe) Study Group.
      J Komulainen, P Kulmala, K Savola, R Lounamaa, J Ilonen, H Reijonen, M Knip and H K Akerblom
      Diabetes Care 1999 Dec; 22 (12): 1950-1955. https://doi.org/10.2337/diacare.22.12.1950

  5. Sawyer, M

    1. Failure to maintain the benefits of home-based intervention in adolescents with poorly controlled type 1 diabetes.
      J J Couper, J Taylor, M J Fotheringham and M Sawyer
      Diabetes Care 1999 Dec; 22 (12): 1933-1937. https://doi.org/10.2337/diacare.22.12.1933

  6. Schade, D S

    1. Low-dose ethanol predisposes elderly fasted patients with type 2 diabetes to sulfonylurea-induced low blood glucose.
      M R Burge, T M Zeise, T A Sobhy, A G Rassam and D S Schade
      Diabetes Care 1999 Dec; 22 (12): 2037-2043. https://doi.org/10.2337/diacare.22.12.2037

  7. Schenck-Gustafsson, K

    1. Education and the metabolic syndrome in women.
      S P Wamala, J Lynch, M Horsten, M A Mittleman, K Schenck-Gustafsson and K Orth-Gomér
      Diabetes Care 1999 Dec; 22 (12): 1999-2003. https://doi.org/10.2337/diacare.22.12.1999

  8. Sedman, AJ

    1. Response to Lin and Ito. Effect of troglitazone on atorvastatin pharmacokinetics and pharmacodynamics
      CM Loi and AJ Sedman
      Diabetes Care 1999 Dec; 22 (12): 2105-2106. https://doi.org/10.2337/diacare.22.12.2105

  9. Selby, J V

    1. Diabetes management in a health maintenance organization. Efficacy of care management using cluster visits.
      C N Sadur, N Moline, M Costa, D Michalik, D Mendlowitz, S Roller, R Watson, B E Swain, J V Selby and W C Javorski
      Diabetes Care 1999 Dec; 22 (12): 2011-2017. https://doi.org/10.2337/diacare.22.12.2011

  10. Selmo, V

    1. Meal-generated oxidative stress in diabetes. The protective effect of red wine.
      A Ceriello, N Bortolotti, E Motz, S Lizzio, A Russo, V Selmo, B Catone, L Tonutti and C Taboga
      Diabetes Care 1999 Dec; 22 (12): 2084-2085. https://doi.org/10.2337/diacare.22.12.2084

  11. Seppälä-Lindroos, A

    1. In vivo endothelial dysfunction characterizes patients with impaired fasting glucose.
      S Vehkavaara, A Seppälä-Lindroos, J Westerbacka, P H Groop and H Yki-Järvinen
      Diabetes Care 1999 Dec; 22 (12): 2055-2060. https://doi.org/10.2337/diacare.22.12.2055

  12. Shamoon, H

    1. Transcutaneous glucose measurement using near-infrared spectroscopy during hypoglycemia.
      I Gabriely, R Wozniak, M Mevorach, J Kaplan, Y Aharon and H Shamoon
      Diabetes Care 1999 Dec; 22 (12): 2026-2032. https://doi.org/10.2337/diacare.22.12.2026

  13. Sharp, L K

    1. The short-term impact of a continuing medical education program on providers' attitudes toward treating diabetes.
      L K Sharp and M S Lipsky
      Diabetes Care 1999 Dec; 22 (12): 1929-1932. https://doi.org/10.2337/diacare.22.12.1929

  14. Sirolla, C

    1. Renal disease as a determinant of increased lipoprotein(a) concentrations in diabetic patients.
      M Boemi, C Sirolla, P Fumelli and R W James
      Diabetes Care 1999 Dec; 22 (12): 2033-2036. https://doi.org/10.2337/diacare.22.12.2033

  15. Snoek, F J

    1. The 12-item well-being questionnaire. An evaluation of its validity and reliability in Dutch people with diabetes.
      F Pouwer, H M van der Ploeg, H J Adèr, R J Heine and F J Snoek
      Diabetes Care 1999 Dec; 22 (12): 2004-2010. https://doi.org/10.2337/diacare.22.12.2004

  16. Sobhy, T A

    1. Low-dose ethanol predisposes elderly fasted patients with type 2 diabetes to sulfonylurea-induced low blood glucose.
      M R Burge, T M Zeise, T A Sobhy, A G Rassam and D S Schade
      Diabetes Care 1999 Dec; 22 (12): 2037-2043. https://doi.org/10.2337/diacare.22.12.2037

  17. Stender, M

    1. Frequency of liver disease in type 2 diabetic patients treated with oral antidiabetic agents.
      S S Jick, M Stender and M W Myers
      Diabetes Care 1999 Dec; 22 (12): 2067-2071. https://doi.org/10.2337/diacare.22.12.2067

  18. Sundkvist, G

    1. Progression of retinopathy after improved metabolic control in type 2 diabetic patients. Relation to IGF-1 and hemostatic variables.
      M Henricsson, K Berntorp, E Berntorp, P Fernlund and G Sundkvist
      Diabetes Care 1999 Dec; 22 (12): 1944-1949. https://doi.org/10.2337/diacare.22.12.1944

  19. Swain, B E

    1. Diabetes management in a health maintenance organization. Efficacy of care management using cluster visits.
      C N Sadur, N Moline, M Costa, D Michalik, D Mendlowitz, S Roller, R Watson, B E Swain, J V Selby and W C Javorski
      Diabetes Care 1999 Dec; 22 (12): 2011-2017. https://doi.org/10.2337/diacare.22.12.2011

  20. Swennen, G N

    1. Lack of effect on LDL oxidation and antioxidant status after improvement of metabolic control in type 2 diabetes.
      W A Oranje, G J Rondas-Colbers, G N Swennen, H Jansen and B H Wolffenbuttel
      Diabetes Care 1999 Dec; 22 (12): 2083-2084. https://doi.org/10.2337/diacare.22.12.2083

T

  1. Taboga, C

    1. Meal-generated oxidative stress in diabetes. The protective effect of red wine.
      A Ceriello, N Bortolotti, E Motz, S Lizzio, A Russo, V Selmo, B Catone, L Tonutti and C Taboga
      Diabetes Care 1999 Dec; 22 (12): 2084-2085. https://doi.org/10.2337/diacare.22.12.2084

  2. Tani, A

    1. Impaired diurnal cardiac autonomic function in subjects with type 2 diabetes.
      M Yamamoto, Y Yamasaki, M Kodama, M Matsuhisa, M Kishimoto, H Ozaki, A Tani, N Ueda, M Iwasaki and M Hori
      Diabetes Care 1999 Dec; 22 (12): 2072-2077. https://doi.org/10.2337/diacare.22.12.2072

  3. Taniguchi, A

    1. Insulin-sensitive and insulin-resistant variants in nonobese Japanese type 2 diabetic patients. The role of triglycerides in insulin resistance.
      A Taniguchi, M Fukushima, M Sakai, K Kataoka, K Miwa, I Nagata, K Doi, K Tokuyama and Y Nakai
      Diabetes Care 1999 Dec; 22 (12): 2100-2101. https://doi.org/10.2337/diacare.22.12.2100

  4. Taylor, J

    1. Failure to maintain the benefits of home-based intervention in adolescents with poorly controlled type 1 diabetes.
      J J Couper, J Taylor, M J Fotheringham and M Sawyer
      Diabetes Care 1999 Dec; 22 (12): 1933-1937. https://doi.org/10.2337/diacare.22.12.1933

  5. Tokuyama, K

    1. Insulin-sensitive and insulin-resistant variants in nonobese Japanese type 2 diabetic patients. The role of triglycerides in insulin resistance.
      A Taniguchi, M Fukushima, M Sakai, K Kataoka, K Miwa, I Nagata, K Doi, K Tokuyama and Y Nakai
      Diabetes Care 1999 Dec; 22 (12): 2100-2101. https://doi.org/10.2337/diacare.22.12.2100

  6. Tonutti, L

    1. Meal-generated oxidative stress in diabetes. The protective effect of red wine.
      A Ceriello, N Bortolotti, E Motz, S Lizzio, A Russo, V Selmo, B Catone, L Tonutti and C Taboga
      Diabetes Care 1999 Dec; 22 (12): 2084-2085. https://doi.org/10.2337/diacare.22.12.2084

  7. Tsang, L W

    1. Two-hour post-glucose loading plasma glucose is the main determinant for the progression from impaired glucose tolerance to diabetes in Hong Kong Chinese.
      G T Ko, J K Li, A Y Cheung, V T Yeung, C C Chow, L W Tsang, C S Cockram and J C Chan
      Diabetes Care 1999 Dec; 22 (12): 2096-2097. https://doi.org/10.2337/diacare.22.12.2096

  8. Tuomilehto, J

    1. Infant feeding, early weight gain, and risk of type 1 diabetes. Childhood Diabetes in Finland (DiMe) Study Group.
      E Hyppönen, M G Kenward, S M Virtanen, A Piitulainen, P Virta-Autio, J Tuomilehto, M Knip and H K Akerblom
      Diabetes Care 1999 Dec; 22 (12): 1961-1965. https://doi.org/10.2337/diacare.22.12.1961
    2. Neonatal anthropometric measurements and risk of childhood-onset type 1 diabetes. DiMe Study Group.
      T Podar, P Onkamo, T Forsen, M Karvonen, E Tuomilehto-Wolf and J Tuomilehto
      Diabetes Care 1999 Dec; 22 (12): 2092-2094. https://doi.org/10.2337/diacare.22.12.2092a

  9. Tuomilehto-Wolf, E

    1. Neonatal anthropometric measurements and risk of childhood-onset type 1 diabetes. DiMe Study Group.
      T Podar, P Onkamo, T Forsen, M Karvonen, E Tuomilehto-Wolf and J Tuomilehto
      Diabetes Care 1999 Dec; 22 (12): 2092-2094. https://doi.org/10.2337/diacare.22.12.2092a

U

  1. Ueda, N

    1. Impaired diurnal cardiac autonomic function in subjects with type 2 diabetes.
      M Yamamoto, Y Yamasaki, M Kodama, M Matsuhisa, M Kishimoto, H Ozaki, A Tani, N Ueda, M Iwasaki and M Hori
      Diabetes Care 1999 Dec; 22 (12): 2072-2077. https://doi.org/10.2337/diacare.22.12.2072

  2. Urbonaite, B

    1. Enterovirus antibodies in relation to islet cell antibodies in two populations with high and low incidence of type 1 diabetes.
      M Lönnrot, M Knip, D Marciulionyte, J Rahko, B Urbonaite, W P Moore, P Vilja and H Hyöty
      Diabetes Care 1999 Dec; 22 (12): 2086-2088. https://doi.org/10.2337/diacare.22.12.2086

V

  1. Valensi, P

    1. Soluble L-selectin level is a marker for coronary artery disease in type 2 diabetic patients.
      J P Albertini, P Valensi, B Lormeau, J Vaysse, J R Attali and L Gattegno
      Diabetes Care 1999 Dec; 22 (12): 2044-2048. https://doi.org/10.2337/diacare.22.12.2044

  2. van der Ploeg, H M

    1. The 12-item well-being questionnaire. An evaluation of its validity and reliability in Dutch people with diabetes.
      F Pouwer, H M van der Ploeg, H J Adèr, R J Heine and F J Snoek
      Diabetes Care 1999 Dec; 22 (12): 2004-2010. https://doi.org/10.2337/diacare.22.12.2004

  3. Vaysse, J

    1. Soluble L-selectin level is a marker for coronary artery disease in type 2 diabetic patients.
      J P Albertini, P Valensi, B Lormeau, J Vaysse, J R Attali and L Gattegno
      Diabetes Care 1999 Dec; 22 (12): 2044-2048. https://doi.org/10.2337/diacare.22.12.2044

  4. Vehkavaara, S

    1. In vivo endothelial dysfunction characterizes patients with impaired fasting glucose.
      S Vehkavaara, A Seppälä-Lindroos, J Westerbacka, P H Groop and H Yki-Järvinen
      Diabetes Care 1999 Dec; 22 (12): 2055-2060. https://doi.org/10.2337/diacare.22.12.2055

  5. Vice, P A

    1. Insulin lispro, pregnancy, and retinopathy.
      A Bhattacharyya and P A Vice
      Diabetes Care 1999 Dec; 22 (12): 2101-2104. https://doi.org/10.2337/diacare.22.12.2101

  6. Vilja, P

    1. Enterovirus antibodies in relation to islet cell antibodies in two populations with high and low incidence of type 1 diabetes.
      M Lönnrot, M Knip, D Marciulionyte, J Rahko, B Urbonaite, W P Moore, P Vilja and H Hyöty
      Diabetes Care 1999 Dec; 22 (12): 2086-2088. https://doi.org/10.2337/diacare.22.12.2086

  7. Virta-Autio, P

    1. Infant feeding, early weight gain, and risk of type 1 diabetes. Childhood Diabetes in Finland (DiMe) Study Group.
      E Hyppönen, M G Kenward, S M Virtanen, A Piitulainen, P Virta-Autio, J Tuomilehto, M Knip and H K Akerblom
      Diabetes Care 1999 Dec; 22 (12): 1961-1965. https://doi.org/10.2337/diacare.22.12.1961

  8. Virtanen, S M

    1. Infant feeding, early weight gain, and risk of type 1 diabetes. Childhood Diabetes in Finland (DiMe) Study Group.
      E Hyppönen, M G Kenward, S M Virtanen, A Piitulainen, P Virta-Autio, J Tuomilehto, M Knip and H K Akerblom
      Diabetes Care 1999 Dec; 22 (12): 1961-1965. https://doi.org/10.2337/diacare.22.12.1961

W

  1. Wägner, A M

    1. Benzodiazepine interruption. Does it cause hypoglycemia?
      A M Wägner, S M Webb and R Corcoy
      Diabetes Care 1999 Dec; 22 (12): 2099. https://doi.org/10.2337/diacare.22.12.2099b

  2. Wamala, S P

    1. Education and the metabolic syndrome in women.
      S P Wamala, J Lynch, M Horsten, M A Mittleman, K Schenck-Gustafsson and K Orth-Gomér
      Diabetes Care 1999 Dec; 22 (12): 1999-2003. https://doi.org/10.2337/diacare.22.12.1999

  3. Watkins, P J

    1. Plantar pressures are elevated in the neuroischemic and the neuropathic diabetic foot.
      D L Pitei, M Lord, A Foster, S Wilson, P J Watkins and M E Edmonds
      Diabetes Care 1999 Dec; 22 (12): 1966-1970. https://doi.org/10.2337/diacare.22.12.1966

  4. Watson, R

    1. Diabetes management in a health maintenance organization. Efficacy of care management using cluster visits.
      C N Sadur, N Moline, M Costa, D Michalik, D Mendlowitz, S Roller, R Watson, B E Swain, J V Selby and W C Javorski
      Diabetes Care 1999 Dec; 22 (12): 2011-2017. https://doi.org/10.2337/diacare.22.12.2011

  5. Webb, S M

    1. Benzodiazepine interruption. Does it cause hypoglycemia?
      A M Wägner, S M Webb and R Corcoy
      Diabetes Care 1999 Dec; 22 (12): 2099. https://doi.org/10.2337/diacare.22.12.2099b

  6. Weinehall, L

    1. Screening for impaired glucose tolerance. Results from a population-based study in 21,057 individuals.
      B Lindahl, L Weinehall, K Asplund and G Hallmans
      Diabetes Care 1999 Dec; 22 (12): 1988-1992. https://doi.org/10.2337/diacare.22.12.1988

  7. Weitzman, S

    1. Impaired fasting glucose is not a risk factor for cardiovascular mortality.
      S Weitzman
      Diabetes Care 1999 Dec; 22 (12): 2104. https://doi.org/10.2337/diacare.22.12.2104b

  8. Westerbacka, J

    1. In vivo endothelial dysfunction characterizes patients with impaired fasting glucose.
      S Vehkavaara, A Seppälä-Lindroos, J Westerbacka, P H Groop and H Yki-Järvinen
      Diabetes Care 1999 Dec; 22 (12): 2055-2060. https://doi.org/10.2337/diacare.22.12.2055

  9. Williams, A J

    1. Progression to diabetes in relatives with islet autoantibodies. Is it inevitable?
      S G Gardner, E A Gale, A J Williams, K M Gillespie, K E Lawrence, G F Bottazzo and P J Bingley
      Diabetes Care 1999 Dec; 22 (12): 2049-2054. https://doi.org/10.2337/diacare.22.12.2049

  10. Wilson, S

    1. Plantar pressures are elevated in the neuroischemic and the neuropathic diabetic foot.
      D L Pitei, M Lord, A Foster, S Wilson, P J Watkins and M E Edmonds
      Diabetes Care 1999 Dec; 22 (12): 1966-1970. https://doi.org/10.2337/diacare.22.12.1966

  11. Wolffenbuttel, B H

    1. Lack of effect on LDL oxidation and antioxidant status after improvement of metabolic control in type 2 diabetes.
      W A Oranje, G J Rondas-Colbers, G N Swennen, H Jansen and B H Wolffenbuttel
      Diabetes Care 1999 Dec; 22 (12): 2083-2084. https://doi.org/10.2337/diacare.22.12.2083

  12. Wozniak, R

    1. Transcutaneous glucose measurement using near-infrared spectroscopy during hypoglycemia.
      I Gabriely, R Wozniak, M Mevorach, J Kaplan, Y Aharon and H Shamoon
      Diabetes Care 1999 Dec; 22 (12): 2026-2032. https://doi.org/10.2337/diacare.22.12.2026

  13. Wu, C H

    1. Discriminating glucose tolerance status by regions of interest of dual-energy X-ray absorptiometry. Clinical implications of body fat distribution.
      C J Chang, C H Wu, F H Lu, J S Wu, N T Chiu and W J Yao
      Diabetes Care 1999 Dec; 22 (12): 1938-1943. https://doi.org/10.2337/diacare.22.12.1938

  14. Wu, J S

    1. Discriminating glucose tolerance status by regions of interest of dual-energy X-ray absorptiometry. Clinical implications of body fat distribution.
      C J Chang, C H Wu, F H Lu, J S Wu, N T Chiu and W J Yao
      Diabetes Care 1999 Dec; 22 (12): 1938-1943. https://doi.org/10.2337/diacare.22.12.1938

Y

  1. Yamada, K

    1. All patients with Werner's syndrome are insulin resistant, but only those who also have impaired insulin secretion develop overt diabetes.
      K Yamada, H Ikegami, H Yoneda, T Miki and T Ogihara
      Diabetes Care 1999 Dec; 22 (12): 2094-2095. https://doi.org/10.2337/diacare.22.12.2094

  2. Yamamoto, M

    1. Impaired diurnal cardiac autonomic function in subjects with type 2 diabetes.
      M Yamamoto, Y Yamasaki, M Kodama, M Matsuhisa, M Kishimoto, H Ozaki, A Tani, N Ueda, M Iwasaki and M Hori
      Diabetes Care 1999 Dec; 22 (12): 2072-2077. https://doi.org/10.2337/diacare.22.12.2072

  3. Yamasaki, Y

    1. Impaired diurnal cardiac autonomic function in subjects with type 2 diabetes.
      M Yamamoto, Y Yamasaki, M Kodama, M Matsuhisa, M Kishimoto, H Ozaki, A Tani, N Ueda, M Iwasaki and M Hori
      Diabetes Care 1999 Dec; 22 (12): 2072-2077. https://doi.org/10.2337/diacare.22.12.2072

  4. Yao, W J

    1. Discriminating glucose tolerance status by regions of interest of dual-energy X-ray absorptiometry. Clinical implications of body fat distribution.
      C J Chang, C H Wu, F H Lu, J S Wu, N T Chiu and W J Yao
      Diabetes Care 1999 Dec; 22 (12): 1938-1943. https://doi.org/10.2337/diacare.22.12.1938

  5. Yeung, V T

    1. Two-hour post-glucose loading plasma glucose is the main determinant for the progression from impaired glucose tolerance to diabetes in Hong Kong Chinese.
      G T Ko, J K Li, A Y Cheung, V T Yeung, C C Chow, L W Tsang, C S Cockram and J C Chan
      Diabetes Care 1999 Dec; 22 (12): 2096-2097. https://doi.org/10.2337/diacare.22.12.2096

  6. Yki-Järvinen, H

    1. In vivo endothelial dysfunction characterizes patients with impaired fasting glucose.
      S Vehkavaara, A Seppälä-Lindroos, J Westerbacka, P H Groop and H Yki-Järvinen
      Diabetes Care 1999 Dec; 22 (12): 2055-2060. https://doi.org/10.2337/diacare.22.12.2055

  7. Yoneda, H

    1. All patients with Werner's syndrome are insulin resistant, but only those who also have impaired insulin secretion develop overt diabetes.
      K Yamada, H Ikegami, H Yoneda, T Miki and T Ogihara
      Diabetes Care 1999 Dec; 22 (12): 2094-2095. https://doi.org/10.2337/diacare.22.12.2094

  8. Young-Hyman, D L

    1. Biopsychobehavioral model of severe hypoglycemia. II. Understanding the risk of severe hypoglycemia.
      D J Cox, L A Gonder-Frederick, B P Kovatchev, D L Young-Hyman, T W Donner, D M Julian and W L Clarke
      Diabetes Care 1999 Dec; 22 (12): 2018-2025. https://doi.org/10.2337/diacare.22.12.2018

Z

  1. Zeise, T M

    1. Low-dose ethanol predisposes elderly fasted patients with type 2 diabetes to sulfonylurea-induced low blood glucose.
      M R Burge, T M Zeise, T A Sobhy, A G Rassam and D S Schade
      Diabetes Care 1999 Dec; 22 (12): 2037-2043. https://doi.org/10.2337/diacare.22.12.2037

  2. Zinman, B

    1. Youth-onset type 2 diabetes (Y2DM) associated with HNF1A S319 in aboriginal Canadians.
      R A Hegele, A J Hanley, B Zinman, S B Harris and C M Anderson
      Diabetes Care 1999 Dec; 22 (12): 2095-2096. https://doi.org/10.2337/diacare.22.12.2095
Back to top